Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2022-12-22 00:00:00 ET · period of report 2022-12-21 · accession 0001209191-22-062530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-22 | 2022-12-21 | ARWR | O'Brien Patrick | GC | M - OptEx | $6.15 | +32.0K | 380.9K | +9% | +$196.8K |
| D | 2022-12-22 | 2022-12-21 | ARWR | O'Brien Patrick | GC | M - OptEx | $0.00 | -32.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-21 | M | A | 32,000 | $6.15 | 380,875 | D | — | — | (F1) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the reporting person which are subject to certain vesting conditions. |
| 2 | Derivative | Stock Option (right to buy Common Stock) | 2022-12-21 | M | D | 32,000 | $0.00 | 0 | D | $6.15 · 2016-02-01 to 2026-01-01 | 32,000 Common Stock | (F2) Represents the first vesting date. Option vested over four years from date of grant. |